Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.378
Peer-review started: September 11, 2022
First decision: October 22, 2022
Revised: November 4, 2022
Accepted: December 23, 2022
Article in press: December 23, 2022
Published online: January 14, 2023
Processing time: 116 Days and 12.6 Hours
The role of histology in ulcerative colitis has evolved over time. Histological activity despite endoscopic remission is associated with poorer clinical outcomes, and various histological scoring systems have been developed. However, the knowledge and attitudes towards the use of histology in the management of ulcerative colitis by gastroenterologists and pathologists is unknown.
Although there has been an increasing literature into the use of histology in ulcerative colitis, it is unknown whether this has translated into knowledge and use by gastroenterologists and pathologists in clinical practice.
The main objective was to evaluate the knowledge of histology guidelines and attitudes towards the use of histology in ulcerative colitis by gastroenterologists and pathologists.
A prospective, cross-sectional survey of gastroenterologists and pathologists was conducted in Australia. The survey was formulated by using peer-reviewed guidelines.
Of 89 responders (77 gastroenterologists, 12 pathologists), there was almost complete acceptance that histological assessment should form part of ulcerative colitis evaluation (95% gastroenterologists, 92% pathologists). However, the majority of both groups lacked awareness of the Geboes score, Nancy index and Robarts histopathological index. Higher knowledge scores were predicted by public hospital attending gastroenterologists and involvement in an inflammatory bowel disease meeting.
Histological remission is a recognised target for both gastroenterologists and pathologists. However knowledge of histological scoring systems was poor.
Future research should involve the development of consensus guidelines in consultation with pathologists on the use of histology in ulcerative colitis management. This should include an agreement on a standardised scoring system to ensure homogenity in reporting across hospitals to permit comparability of biopsies.